Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer

Objectives. To evaluate the efficacy and safety of personalized peptide vaccination (PPV) combined with chemotherapy for patients with previously treated advanced non-small-cell lung cancer (NSCLC). Patients and Methods. Previously treated PS0-1 patients with IIIB/IV EGFR (epidermal growth factor re...

Descripción completa

Detalles Bibliográficos
Autores principales: Takayama, Koichi, Sugawara, Shunichi, Saijo, Yasuo, Maemondo, Makoto, Sato, Atsushi, Takamori, Shinzo, Harada, Taishi, Sasada, Tetsuro, Kakuma, Tatsuyuki, Kishimoto, Junji, Yamada, Akira, Noguchi, Masanori, Itoh, Kyogo, Nakanishi, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870343/
https://www.ncbi.nlm.nih.gov/pubmed/27274999
http://dx.doi.org/10.1155/2016/1745108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870343/
https://www.ncbi.nlm.nih.gov/pubmed/27274999
http://dx.doi.org/10.1155/2016/1745108

Ejemplares similares